Atlas Trials

Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

Clinical trial NCT03249064 · COMPLETED

Trial details

NCT number
NCT03249064
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status
COMPLETED
Study type
OBSERVATIONAL
VITILIGO
Start date
2015-10-27
Primary completion
2016-09-13
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.